Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Traditional Chinese medicine antihypertensive granules is a botanical formulation developed by the Affiliated Hospital of Shandong University of TCM for the treatment of isolated systolic hypertension (ISH). The drug is administered as oral granules and is intended as an early intervention to lower blood pressure and protect vascular function, specifically aiming to delay the progression of vascular dysfunction in untreated patients. It was evaluated in a single-center clinical study (ChiCTR-INR-15007539) in China. As a traditional Chinese medicine (TCM) product, it likely utilizes a multi-component approach to address the underlying patterns of hypertension according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on traditional Chinese medicine antihypertensive granules.